Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
339
datasets available to search
ShareScore release 0.9.0
Dataset results
339 results for “CML”
Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)
ClinicalTrials.gov study NCT03547154. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov study NCT01397734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine and HQP1351-based Chemotherapy Regimen for the Treatment Advanced CML
ClinicalTrials.gov study NCT05376852. IPD Sharing: NO. Countries: 1. Publications: 0.
Study Conducted Among Patients With CML
ClinicalTrials.gov study NCT05476562. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
ClinicalTrials.gov study NCT04925141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov study NCT00185523. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DC Vaccination in CML
ClinicalTrials.gov study NCT02543749. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients
ClinicalTrials.gov study NCT05434312. IPD Sharing: NO. Countries: 1. Publications: 0.
Telemonitoring Study - for Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT01490983. IPD Sharing: NO. Countries: 1. Publications: 0.
PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML
ClinicalTrials.gov study NCT00303290. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Retrospective Evaluation of CML Patients in the National Compassionate Program
ClinicalTrials.gov study NCT02448095. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)
ClinicalTrials.gov study NCT01221376. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Population Pharmacokinetics of Imatinib in CML Patients in Iran
ClinicalTrials.gov study NCT02146846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT01460498. IPD Sharing: Not stated. Countries: 1. Publications: 0.
2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients
ClinicalTrials.gov study NCT02917720. IPD Sharing: NO. Countries: 2. Publications: 0.
CML Treated With Bosutinib After Relapse
ClinicalTrials.gov study NCT02445742. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to Gleevec
ClinicalTrials.gov study NCT00661180. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan
ClinicalTrials.gov study NCT00337454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Free Remission (TFR) in CML Patients （CML-CP）Study
ClinicalTrials.gov study NCT05440747. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting
ClinicalTrials.gov study NCT04089839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.